48
Views
0
CrossRef citations to date
0
Altmetric
Review

Community-Acquired Methicillin-Resistant Staphylococcus Aureus: A Growing Public Health Problem

&
Pages 95-105 | Published online: 16 Oct 2007

Bibliography

  • Rathore MH , KlineMW: Community-acquired methicillin-resistant Staphylococcus aureus infections in children.Pediatr. Infect. Dis. J.8, 645–647(1989).
  • Moreno F , CrispC, JorgensenJH, Patterson JE: Methicillin-resistant Staphylococcus aureusas a community organism. Clin. Infect. Dis.21, 1308–1312(1995).
  • Layton MC , HierholzerWJ, PattersonJE: The evolving epidemiology of methicillin-resistant Staphylococcus aureus at a university hospital.Infect. Control. Hosp. Epidemiol.16, 12–17(1995).
  • Herold BC , ImmergluckLC, MarananMCet al.: Community-acquired methicillin-resistant Staphylococcus aureus in children with no predisposing risk. JAMA279, 593–598(1998).
  • Centers for Disease Controland Prevention: Four pediatric deaths from community-acquired methicillin-resistant Staphylococcal aureus – Minnesota and North Dakota, 1997–1999. MMWR48, 707–710(1999).
  • Gorak EJ , YamadaSM, BrownJD: Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors.Clin. Infect. Dis.29, 797–800(1999).
  • Frank AL , MarcinakJF, MangatPD, SchreckenbergerPC: Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children.Pediatr. Infect. Dis. J.18, 993–1000(1999).
  • Frank AL , MarcinakJF, MangatPD, SchreckenbergerPC: Increase in community-acquired methicillin-resistant Staphylococcus aureus in children.Clin. Infect. Dis.29, 935–936(1999).
  • Hussain FM , Boyle-VavraS, BethelCD, DaumRS: Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility.Pediatr. Infect. Dis. J.19, 1163–1166(2000).
  • Fergie JE , PurcellK: Community-acquired methicillin-resistant Staphylococcus aureus infections in South Texas children.Pediatr. Infect. Dis. J.20, 860–863(2001).
  • Groom AV , WolseyDH, NaimiTSet al.: Community-acquired methicillin-resistant Staphylococcus aureus infections in a rural American Indian community. JAMA286, 1201–1205(2001).
  • Purcell K , FergieJ: Exponential increase in community-acquired methicillin-resistant Staphylococcus aureus in South Texas children.Pediatr. Infect. Dis. J.21, 988–989(2002).
  • Sattler CA , MasonEO, KaplanSL: Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infections in children.Pediatr. Infect. Dis. J.21, 910–916(2002).
  • Naimi TS , LeDellKH, Como-SabettiKet al.: Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA290, 2976–2984(2003).
  • Buckingham SC , McDougalLK, Cathey D et al.: Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children’s Hospital. Pediatr. Infect. Dis. J.23, 619–624(2004).
  • Alfaro C , FergieJ, PurcellK: Emergence of community-acquired methicillin-resistant Staphylococcus aureus in complicated parapneumonic effusions.Pediatr. Infect. Dis. J.24, 274–276(2005).
  • Kaplan SL , HultenKG, GonzalezBEet al.: Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin. Infect. Dis.40, 1785–1791(2005).
  • Purcell K , FergieJ: Epidemic of community-acquired methicillin-resistant Staphylococcus aureus infections: a 14-year study at Driscoll Children’s Hospital.Arch. Pediatr. Adolesc. Med.159, 980–985(2005).
  • Vandenesch F , NaimiT, EnrightMCet al.: Community-acquired methicillin-resistant Staphylococcus aureus carryng Panton–Valentine leukocidin genes: worldwide emergence. Emerg. Infect. Dis.9, 978–984(2003).
  • Barrett FF , McGeheeRF, FinlandM: Methicillin-resistant Staphylococcus aureus at Boston City Hospital.N. Engl. J. Med.279, 441–448(1968).
  • Lowy FD : Staphylococcus aureus infections.N. Engl. J. Med.339, 520–532(1998).
  • Centers for Disease Control and Prevention: Community-acquired methicillin-resistant Staphylococcal aureus infections – Michigan. MMWR30, 185–187(1981).
  • Adcock PM , PastorP, MedleyF, Patterson JE, Murphy TV: Methicillin-resistant Staphylococcus aureus in two child care centers. J. Infect. Dis.178, 577–580(1998).
  • Lindenmayer JM , SchoenfeldS, O‘Grady R, Carney JK: Methicillin-resistant Staphylococcal aureus in a high school wrestling team and the surrounding community. Arch. Intern. Med.158, 895–899(1998).
  • Shahin R , JohnsonIL, JamiesonF, McGeerA, TolkinJ, Ford-JonesEL: Methicillin-resistant Staphylococcus aureus carriage in a child care center following a case of disease.Arch. Pediatr. Adolesc. Med.153, 864–868(1999).
  • Suggs AH , MarananMC, Boyle-VavraS, DaumRS: Methicillin-resistant and borderline methicillin-resistant asymptomatic Staphylococcus aureus colonization in children without identifiable risk factors.Pediatr. Infect. Dis. J.18, 410–414(1999).
  • Hussain FM , Boyle-VavraS, DaumRS: Community-acquired methicillin-resistant Staphylococcus aureus colonization in healthy children attending an outpatient pediatric clinic.Pediatr. Infect. Dis. J.20, 763–767(2001).
  • Nakamura MM , RohlingKL, ShashatyMet al.: Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in the community pediatric population. Pediatr. Infect. Dis. J.21, 917–921(2002).
  • Immergluck LC , KanungoS, SchwartzAet al.: Prevalence of Streptococcus pneumoniae and Staphylococcus aureus nasopharyngeal colonization in healthy children in the United States. Epidemiol. Infect.132, 159–166(2004).
  • Creech CB , KernodleDS, AlsentzerAet al.: Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr. Infect. Dis. J.24, 617–621(2005).
  • Foglia EE , DubberkeE, RenoHet al.: Nasal carriage of Staphylococcus aureus and MRSA: point prevalence study in children. Proceedings of the Society for Healthcare Epidemiology of America 2005 Annual Meeting. Los Angeles, CA, USA (2005).
  • Alfaro C , Mascher-DenenM, FergieJ, PurcellK: Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in patients admitted to Driscoll Children’s Hospital.Pediatr. Infect. Dis. J.25, 459–461(2006).
  • Purcell K , FergieJ: Increase in hospitalizations for cellulitis and abscess concurrent with the epidemic of community-acquired methicillin-resistant Staphylococcus aureus infections in children. Proceedings of the 2005 Annual Meeting of the Pediatric Academic Societies. Washington, DC, USA (2005).
  • Purcell K , FergieJ, PetersonMD: Economic impact of the community-acquired methicillin-resistant Staphylococcus aureus epidemic on the Driscoll Children’s Health Plan.Pediatr. Infect. Dis. J.25, 178–180(2006).
  • Ito T , MaXX, TakeuchiFet al.: Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob. Agents Chemother.48, 2637–2651(2004).
  • McDougal LK , StewardCD, KillgoreGEet al.: Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J. Clin. Microbiol.41, 5113–5120(2003).
  • Diep BA , GillSR, ChangRFet al.: Complete genome sequence of USA 300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet367, 731–739(2006).
  • Gillet Y , IssartelB, VanhemsPet al.: Association between Staphylococcus aureus strains carrying gene for Panton–Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet359, 753–759(2002).
  • Gonzalez BE , HultenKG, DishopMKet al.: Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin. Infect. Dis.41, 583–590(2005).
  • Gonzalez BE , Martinez-AguilarG, Hulten KG et al.: Severe staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatr.115, 642–648(2005).
  • Yamasaki O , KanekoJ, MorizaneSet al.: The association between Staphylococcus aureus strains carrying Panton–Valentine leukocidin genes and the development of deep-seated follicular infection. Clin. Infect. Dis.40, 381–385(2005).
  • Voyich JM , OttoM, MathemaBet al.: Is Panton–Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J. Infect. Dis.194, 1761–1770(2006).
  • Zaoutis TE , ToltzisP, ChuJet al.: Clinical and molecular epidemiology of community-acquired methicillin-resistant Staphylococcus aureus infections among children with risk factors for healthcare-associated infections, 2001–2003. Pediatr. Infect. Dis. J.25, 343–348(2006).
  • Kluytmans J , van Belkum A, Verbrugh H: Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin. Microbiol. Rev.10, 505–520(1997).
  • Huang SS , PlattR: Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization.Clin. Infect. Dis.36, 281–285(2003).
  • von Eiff C , BeckerK, MachkaKet al.: Nasal carriage as a source of Staphylococcus aureus bacteremia. N. Engl. J. Med.344, 11–16(2001).
  • Wertheim HFL , VosMC, OttAet al.: Risk and outcome of nosocomial Staphylococcus aureus bacteremia in nasal carriers versus non-carriers. Lancet364, 703–705(2004).
  • Davis KA , StewartJJ, CrouchHKet al.: Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin. Infect. Dis.39, 776–782(2004).
  • Ellis MW , HospenthalDR, DooleyDPet al.: Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin. Infect. Dis.39, 971–979(2004).
  • Farrow S , KnobC, BarryCet al.: Vaginal–rectal carriage of Staphylococus aureus and community-acquired MRSA in pregnant women. Proceedings of the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA, USA (2006) (Abstract C2–605) .
  • Gastelum DT , DasseyD, MascolaL, Yasuda LM: Transmission of community-associated methicilin-resistant Staphylococcus aureus from breast milk in the neonatal intensive care unit. Ped. Infect. Dis. J.24, 1122–1124(2005).
  • Stein M , Navon-VeneziaS, ChmelnitskyIet al.: An outbreak of new, nonmultidrug-resistant, methicillin-resistant Staphylococcus aureus strain (SCCmec type IIIa variant-1) in the neonatal intensive care unit by a staff member. Pediatr. Infect. Dis. J.25, 557–558(2006).
  • Centers for Disease Control and Prevention: Methicillin-resistant Staphylococcus aureus infections among tattoo recipients – Ohio, Kentucky, and Vermont, 2004–2005. MMWR55, 677–679(2006).
  • Adem PV , MontgomeryCP, HusainANet al.: Staphylococcus aureus sepsis and Waterhouse–Friderichsen syndrome in children. N. Engl. J. Med.353, 1245–1251(2005).
  • Fortunov RM , HultenKG, HammermanWAet al.: Community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates. Pediatr.118, 874–881(2006).
  • Braun L , CraftD, WilliamsRet al.: Increasing clindamycin resistance among methicillin-resistant Staphylococcus aureus in 57 northeast United States military treatment facilities. Pediatr. Infect. Dis. J.24, 622–626(2005).
  • Frank AL , MarcinakJF, MangatPDet al.: Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr. Infect. Dis. J.21, 530–534(2002).
  • Baker CJ , FrenckRW: Change in management of skin/soft tissue infections needed.AAP News25, 105 (2004).
  • Stevens DL , BisnoAL, ChambersHFet al.: Practice guidelines for the diagnosis and management of skin and soft tissue infections. Clin. Infect. Dis.41, 1373–1406(2005).
  • Lee MC , RiosAM, AtenMFet al.: Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr. Infect. Dis. J.23, 123–127(2004).
  • Martinez-Aguilar G , HammermanWA, MasonEO, KaplanSL: Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children.Pediatr. Infect. Dis. J.22, 593–598(2003).
  • Siberry GK , TekleT, CarrollK, DickJ: Failure of clindamyin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro.Clin. Infect. Dis.37, 1257–1260(2003).
  • Drinkovic D , FullerER, ShoreKPet al.: Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J. Antimicrob. Chemother.48, 315–316(2001).
  • Wunderink R , RelloJ, CammarataSKet al.: Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.Chest124, 1789–1797(2003).
  • Ardura M , MejiasA, McCrackenGHet al.: Daptomycin therapy for multi-drug resistant gram-positive bacterial infections in children. Proceedings of the 44th Annual Meeting of the Infectious Diseases Society of America. Toronto, ON, Canada (2006).
  • Shinefield HR , BlackS: Prospects for active and passive immunization against Staphylococcus aureus.Pediatr. Infect. Dis. J.25, 167–168(2006).
  • Muto CA , JerniganJA, OstrowskyBEet al.: SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect. Control. Hosp. Epidemiol.24, 362–386(2003).
  • Laupland KB , ConlyJM: Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review.Clin. Infect. Dis.37, 933–938(2003).
  • Cavdar C , AtayT, ZeybelMet al.: Emergence of resistance in staphylococci after long-term mupirocin application in patients on continuous ambulatory peritoneal dialysis. Peritoneal Dialysis Bulletin20, 67–70(2004).
  • Vasquez JE , WalkerES, FranzusBWet al.: The epidemiology of mupirocin resistance among methicillin-resistant at a Veterans’ Affairs hospital. Infect. Control. Hosp. Epidemiol.21, 459–464(2000).
  • Centers for Disease Control and Prevention: Methicillin-resistant Staphylococcus aureus infections among competitive sports participants – Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000–2003. MMWR52, 793–795(2003).
  • Critchley IA : Eradication of MRSA nasal colonization as a strategy for infection prevention. Drug Discov. Today: Therapeutic Strategies3, 189–195(2006).
  • Cepeda JA , WhitehouseT, CooperBet al.: Isolation of patients in single rooms or cohorts to reduce the spread of MRSA in intensive care units: prospective two-centre study. Lancet365, 295–304(2005).
  • Kalmeijer MD , CoertjensH, van Nieuwland-Bollen PM et al.: Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin. Infect. Dis.35, 353–358(2002).
  • Perl TM , CullenJJ, WenzelRPet al.: Mupirocin and the Risk of Staphylococcus aureus Study Team. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N. Engl. J. Med.346, 1871–1877(2002).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.